Bu liste, son piyasa olaylarına dayalı bir analizdir. Yatırım tavsiyesi değildir.
Hakkında
Health Technology
Biotechnology
Manufacturing
Pharmaceutical Preparation Manufacturing
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologies; and Processa Pharmaceuticals. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.
Show more...
CEO
Roger Tung
Çalışanlar
64
Ülke
Amerika Birleşik Devletleri
ISIN
US2060221056
WKN
000A1XEAC
Kotasyonlar
0 Comments
Düşüncelerini paylaş
FAQ
Concert Pharmaceuticals hissesinin bugünkü fiyatı nedir?▼
CNCE’un güncel fiyatı $8,37 USD — son 24 saatte %+0,12% arttı. Concert Pharmaceuticals hissesinin fiyat performansını grafikte daha yakından izle.